Leave a Reply

Next Post

Mylan to pay $30 million U.S. SEC fine related to EpiPen overcharge probe

FIlE PHOTO: Logo of Mylan Laboratories, a company primarily engaged in the commercialization of generic drugs is pictured in Merignac near Bordeaux, France, September 19, 2019. REUTERS/Regis Duvignau September 28, 2019 By Jonathan Stempel (Reuters) – Mylan NV has agreed to pay a $30 million fine to settle U.S. Securities […]